Treatment of Ectopic Calcification in Fahr's Disease or Syndrome

PHASE2RecruitingINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 3, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Fahr DiseaseFahr SyndromePrimary Familial Brain Calcification
Interventions
DRUG

Etidronate

The dosage of etidronate is 20 mg/kg for twee weeks and ten weeks off. Etidronate is given in capsules of 200 mg. Etidronate capsules are administered orally. During the study, participants will receive etidronate in four periods of two weeks during the twelve months of follow-up.

DRUG

Placebo

Placebo is given in capsules and are administered orally. During the study, participants will receive placebo in four periods of two weeks during the twelve months of follow-up.

Trial Locations (2)

3584 CX

RECRUITING

University Medical Center Utrecht, Utrecht

Unknown

NOT_YET_RECRUITING

University College London Hospital, London

All Listed Sponsors
collaborator

Netherlands Brain Foundation

OTHER

lead

UMC Utrecht

OTHER